Seuraa
Jode Goodridge
Jode Goodridge
Muut nimetJodie Peter Goodridge
Fate Therapeutics
Vahvistettu sähköpostiosoite verkkotunnuksessa fatetherapeutics.com
Nimike
Viittaukset
Viittaukset
Vuosi
CD56bright NK cells exhibit potent antitumor responses following IL-15 priming
JA Wagner, M Rosario, R Romee, MM Berrien-Elliott, SE Schneider, ...
The Journal of clinical investigation 127 (11), 4042-4058, 2017
3252017
Critical role of CD2 co-stimulation in adaptive natural killer cell responses revealed in NKG2C-deficient humans
LL Liu, J Landskron, EH Ask, M Enqvist, E Sohlberg, JA Traherne, ...
Cell reports 15 (5), 1088-1099, 2016
2342016
Killer Ig-like receptor expression in uterine NK cells is biased toward recognition of HLA-C and alters with gestational age
AM Sharkey, L Gardner, S Hiby, L Farrell, R Apps, L Masters, J Goodridge, ...
The Journal of Immunology 181 (1), 39-46, 2008
1702008
HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors
JP Goodridge, A Burian, N Lee, DE Geraghty
The Journal of Immunology 191 (7), 3553-3562, 2013
1592013
KIR2DL4 (CD158d) genotype influences expression and function in NK cells
JP Goodridge, CS Witt, FT Christiansen, HS Warren
The Journal of Immunology 171 (4), 1768-1774, 2003
1572003
Remodeling of secretory lysosomes during education tunes functional potential in NK cells
JP Goodridge, B Jacobs, ML Saetersmoen, D Clement, Q Hammer, ...
Nature communications 10 (1), 514, 2019
1222019
HLA-F complex without peptide binds to MHC class I protein in the open conformer form
JP Goodridge, A Burian, N Lee, DE Geraghty
The Journal of Immunology 184 (11), 6199-6208, 2010
1052010
Maternal KIR repertoire is not associated with recurrent spontaneous abortion
CS Witt, J Goodridge, MG Gerbase-Delima, S Daher, FT Christiansen
Human reproduction 19 (11), 2653-2657, 2004
902004
Intrinsic functional potential of NK-cell subsets constrains retargeting driven by chimeric antigen receptors
VYS Oei, M Siernicka, A Graczyk-Jarzynka, HJ Hoel, W Yang, D Palacios, ...
Cancer immunology research 6 (4), 467-480, 2018
872018
Three common alleles of KIR2DL4 (CD158d) encode constitutively expressed, inducible and secreted receptors in NK cells
JP Goodridge, LJ Lathbury, NK Steiner, CN Shulse, P Pullikotil, ...
European journal of immunology 37 (1), 199-211, 2007
792007
Growth in the Presence of Salicylate Increases Fluoroquinolone Resistance in Staphylococcus aureus
JE Gustafson, PV Candelaria, SA Fisher, JP Goodridge, TM Lichocik, ...
Antimicrobial Agents and Chemotherapy 43 (4), 990-992, 1999
781999
Newtonian cell interactions shape natural killer cell education
JP Goodridge, B Önfelt, KJ Malmberg
Immunological reviews 267 (1), 197-213, 2015
752015
Analysis of HLA A* 02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial
AJ Gartland, S Li, J McNevin, GD Tomaras, R Gottardo, H Janes, Y Fong, ...
Journal of virology 88 (15), 8242-8255, 2014
742014
HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway
JP Goodridge, N Lee, A Burian, CW Pyo, SS Tykodi, EH Warren, C Yee, ...
The Journal of Immunology 191 (4), 1567-1577, 2013
742013
FT596: translation of first-of-kind multi-antigen targeted off-the-shelf CAR-NK cell with engineered persistence for the treatment of B cell malignancies
JP Goodridge, S Mahmood, H Zhu, S Gaidarova, R Blum, R Bjordahl, ...
Blood 134, 301, 2019
632019
Killer Ig-like receptor 2DL4 does not mediate NK cell IFN-γ responses to soluble HLA-G preparations
MEL Le Page, JP Goodridge, E John, FT Christiansen, CS Witt
The Journal of Immunology 192 (2), 732-740, 2014
572014
Immune selection during tumor checkpoint inhibition therapy paves way for NK-cell “missing self” recognition
KJ Malmberg, E Sohlberg, JP Goodridge, HG Ljunggren
Immunogenetics 69 (8), 547-556, 2017
442017
Harnessing adaptive natural killer cells in cancer immunotherapy
LL Liu, A Pfefferle, VOY Sheng, AT Björklund, V Béziat, JP Goodridge, ...
Molecular oncology 9 (10), 1904-1917, 2015
442015
Naive donor NK cell repertoires associated with less leukemia relapse after allogeneic hematopoietic stem cell transplantation
AT Björklund, T Clancy, JP Goodridge, V Béziat, M Schaffer, E Hovig, ...
The Journal of Immunology 196 (3), 1400-1411, 2016
402016
Intra-lineage plasticity and functional reprogramming maintain natural killer cell repertoire diversity
A Pfefferle, B Jacobs, H Netskar, EH Ask, S Lorenz, T Clancy, ...
Cell reports 29 (8), 2284-2294. e4, 2019
382019
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20